Jubilant LifeScience informs about unaudited financial results

25 Oct 2019 Evaluate

In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), Jubilant LifeScience has informed that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended September 30, 2019 were approved by the Board of Directors of the Company at its meeting held today at 1.00 p.m. and concluded at 3.40 p.m. Pursuant to the applicable provisions of the Listing Regulations, the Company has enclosed the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended September 30, 2019; Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and copies of the Press Release and Presentation.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×